ECL · Ecolab Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $16.08B | $15.74B | $15.32B | $14.19B | $12.73B | $11.79B |
| Cost of Revenue | $8.93B | $8.90B | $9.15B | $8.83B | $7.62B | $6.91B |
| Gross Profit | $7.15B | $6.84B | $6.17B | $5.36B | $5.12B | $4.88B |
| R&D | $202.00M | $207.00M | $192.00M | $190.00M | $186.00M | $185.00M |
| SG&A | $4.26B | $4.23B | $4.06B | $3.65B | $3.42B | $3.31B |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $672.60M | $634.90M | $616.70M | $618.50M | $604.40M | $594.30M |
| Operating Income | $2.74B | $2.80B | $1.99B | $1.56B | $1.60B | $1.40B |
| Interest Expense | $306.20M | $340.30M | $348.90M | $252.10M | $230.60M | $304.80M |
| Income Tax | $454.60M | $439.30M | $362.50M | $234.50M | $270.20M | $176.60M |
| Net Income | $2.08B | $2.11B | $1.09B | $1.09B | $1.13B | ($1.21B) |
| EPS - Basic | $7.33 | $7.43 | $4.82 | $3.83 | $3.95 | ($4.20) |
| EPS - Diluted | $7.28 | $7.37 | $4.79 | $3.81 | $3.91 | ($4.15) |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $646.20M | $1.26B | $919.50M | $598.60M | $359.90M | $1.26B |
| Accounts Receivable | $3.25B | $2.87B | $2.83B | $2.70B | $2.48B | $2.27B |
| Inventory | $1.49B | $1.46B | $1.50B | $1.79B | $1.49B | $1.29B |
| Accounts Payable | $2.07B | $1.81B | $1.57B | $1.73B | $1.38B | $1.16B |
| Current Assets | $5.96B | $6.03B | $5.64B | $5.49B | $4.69B | $5.12B |
| Total Assets | $24.70B | $22.39B | $21.85B | $21.46B | $21.21B | $18.13B |
| Current Liabilities | $5.53B | $4.79B | $4.35B | $4.21B | $3.55B | $2.93B |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $14.89B | $13.60B | $13.77B | $14.21B | $13.95B | $11.92B |
| Stockholders' Equity | $9.77B | $8.76B | $8.04B | $7.24B | $7.22B | $6.17B |
| Retained Earnings | $12.83B | $11.52B | $10.08B | $9.32B | $8.81B | $8.24B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.95B | $2.81B | $2.41B | $1.79B | $2.06B | $1.86B |
| Investing Cash Flow | ($2.71B) | ($433.80M) | ($990.50M) | ($716.80M) | ($4.58B) | ($414.50M) |
| Financing Cash Flow | ($853.30M) | ($2.02B) | ($1.05B) | ($837.30M) | $1.60B | ($341.80M) |
| CapEx | $1.05B | $994.50M | $774.80M | $712.80M | $643.00M | $489.00M |
| Free Cash Flow | $1.90B | $1.82B | $1.64B | $1.08B | $1.42B | $1.37B |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 44.5% | 43.5% | 40.2% | 37.8% | 40.2% | 41.4% |
| Operating margin | 17.0% | 17.8% | 13.0% | 11.0% | 12.6% | 11.8% |
| EBITDA margin | 21.2% | 21.8% | 17.0% | 15.4% | 17.3% | 16.9% |
| Net margin | 12.9% | 13.4% | 7.1% | 7.7% | 8.9% | -10.2% |
| Free cash flow margin | 11.8% | 11.6% | 10.7% | 7.6% | 11.1% | 11.6% |
| FCF / Net income | 0.92 | 0.86 | 1.50 | 0.99 | 1.26 | -1.14 |
| R&D / Revenue | 1.3% | 1.3% | 1.3% | 1.3% | 1.5% | 1.6% |
| SG&A / Revenue | 26.5% | 26.9% | 26.5% | 25.8% | 26.8% | 28.1% |
| Effective tax rate | 18.0% | 17.2% | 24.9% | 17.7% | 19.3% | - |
| Return on assets | 8.4% | 9.4% | 5.0% | 5.1% | 5.3% | -6.6% |
| Return on equity | 21.2% | 24.1% | 13.6% | 15.1% | 15.6% | -19.5% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 1.08 | 1.26 | 1.30 | 1.30 | 1.32 | 1.75 |
| Quick ratio | 0.81 | 0.95 | 0.95 | 0.88 | 0.90 | 1.31 |
| Cash ratio | 0.12 | 0.26 | 0.21 | 0.14 | 0.10 | 0.43 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | 8.9x | 8.2x | 5.7x | 6.2x | 6.9x | 4.6x |
| Equity multiplier | 2.53 | 2.56 | 2.72 | 2.97 | 2.94 | 2.94 |
| Liabilities / Assets | 0.60 | 0.61 | 0.63 | 0.66 | 0.66 | 0.66 |
| Efficiency | ||||||
| Asset turnover | 0.65 | 0.70 | 0.70 | 0.66 | 0.60 | 0.65 |
| Inventory turnover | 5.99 | 6.08 | 6.11 | 4.93 | 5.11 | 5.37 |
| Days sales outstanding | 74d | 66d | 68d | 69d | 71d | 70d |
| Days inventory outstanding | 61d | 60d | 60d | 74d | 71d | 68d |
| Days payable outstanding | 85d | 74d | 62d | 71d | 66d | 61d |
| Cash conversion cycle | 50d | 52d | 65d | 72d | 76d | 77d |
| Valuation | ||||||
| P / E | 36.1x | 31.8x | 41.4x | 38.2x | 60.0x | - |
| P / B | 7.7x | 7.7x | 7.1x | 5.8x | 9.4x | 10.2x |
| P / S | 4.7x | 4.3x | 3.7x | 2.9x | 5.3x | 5.3x |
| EV / EBITDA | 21.8x | 19.2x | 21.4x | 18.9x | 30.6x | 30.9x |
| Growth | ||||||
| Revenue growth (YoY) | 2.2% | 2.7% | 8.0% | 11.4% | 8.0% | -20.9% |
| Revenue CAGR (3y) | 4.3% | 7.3% | 9.1% | -1.6% | -1.1% | -5.2% |
| Revenue CAGR (5y) | 6.4% | 1.1% | 3.1% | 0.5% | -0.6% | -2.7% |
| Gross profit growth (YoY) | 4.5% | 11.0% | 15.1% | 4.7% | 4.8% | -21.0% |
| Operating income growth (YoY) | -2.3% | 40.7% | 27.5% | -2.3% | 14.5% | -30.7% |
| Net income growth (YoY) | -1.7% | 93.5% | 0.0% | -3.4% | - | - |
| EPS growth (YoY) | -1.2% | 53.9% | 25.7% | -2.6% | - | - |
| EPS CAGR (3y) | 24.1% | 23.5% | - | -10.6% | -7.1% | - |
| EPS CAGR (5y) | - | 6.7% | -0.4% | -5.8% | -1.1% | - |
| FCF growth (YoY) | 4.7% | 11.1% | 52.2% | -24.2% | 3.5% | -15.4% |
| FCF CAGR (5y) | 6.8% | 2.3% | 2.7% | -1.3% | 2.9% | 2.2% |
| Book value growth (YoY) | 11.6% | 8.9% | 11.2% | 0.2% | 17.2% | -29.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$16.08B totalWater Services$7.98B · 49.6%
Global Institutional$6.10B · 38.0%
Global Pest Elimination$1.25B · 7.8%
Global Healthcare And Life Sciences$747.90M · 4.7%
Product / service
$16.08B totalProduct And Equipment$12.62B · 78.5%
Service And Lease$3.46B · 21.5%
Geographic
$7.98B totalUS$3.42B · 42.8%
Europe$1.66B · 20.8%
Asia Pacific$945.70M · 11.8%
Latin America$816.70M · 10.2%
India Middle East And Africa$501.10M · 6.3%
CN$410.40M · 5.1%
CA$232.30M · 2.9%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
1.72
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✓Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Comparing ECOLAB INC. against the 5 most active filers in the same SIC group.
Dividends
$2.76/share trailing 12 months · +13.1% YoY
| Ex-date | Per share |
|---|---|
| Mar 17, 2026 | $0.7300 |
| Dec 16, 2025 | $0.7300 |
| Sep 16, 2025 | $0.6500 |
| Jun 17, 2025 | $0.6500 |
| Mar 18, 2025 | $0.6500 |
| Dec 17, 2024 | $0.6500 |
| Sep 17, 2024 | $0.5700 |
| Jun 18, 2024 | $0.5700 |
| Mar 18, 2024 | $0.5700 |
| Dec 18, 2023 | $0.5700 |
| Sep 18, 2023 | $0.5300 |
| Jun 16, 2023 | $0.5300 |
| Mar 20, 2023 | $0.5300 |
| Dec 19, 2022 | $0.5300 |
| Sep 19, 2022 | $0.5100 |
| Jun 17, 2022 | $0.5100 |
| Mar 14, 2022 | $0.5100 |
| Dec 13, 2021 | $0.5100 |
| Sep 13, 2021 | $0.4800 |
| Jun 14, 2021 | $0.4800 |
| Mar 15, 2021 | $0.4800 |
| Dec 14, 2020 | $0.4800 |
| Sep 14, 2020 | $0.4700 |
| Jun 15, 2020 | $0.4700 |